We also took into account the expression of two aggressiveness markers, CD133, a widely used marker for isolating cancer stem cell (CSC), and N-Cadherin (NCAD), a well-known marker for epithelial-to-mesenchymal transition (EMT) [17]. Here, CDH2 is linked to cancer.